-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Abnormal blood sodium is an independent predictor of mortality in patients with bacterial pneumonia.
Coronavirus disease
Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.
The study included 488 patients (median age 68 years).
It can be seen that abnormal blood sodium during hospitalization is a risk factor for poor prognosis of COVID-19 patients, and hypernatremia and hyponatremia are respectively associated with greater risks of death and respiratory failure.
Abnormal blood sodium during hospitalization is a risk factor for poor prognosis of COVID-19 patients.
Original source:
Ploutarchos Tzoulis.
org/10.
1210/clinem/dgab107" target="_blank" rel="noopener">Dysnatremia is a predictor for morbidity and mortality in hospitalized patients with COVID-19 in this message